72.11.Z - Scientific research and development activities
10.20.Z - Processing and preserving of fish, crustaceans, and mollusks
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
46.38.Z - Wholesale trade of other food products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
47.99.Z - Retail trade
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
2022 | 2023 | 2024 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 21,3 | 3,9 | 3 | -23,6 |
EBITDA | 21,3 | 4,1 | 3 | -26,3 |
Short time liabilities | 10,7 | 15,2 | 32,6 | 114,5 |
Equity capital | 31,6 | 35,2 | 38 | 7,8 |
Operating profit (EBIT) | 21,3 | 4,1 | 3 | -26,3 |
Assets | 42,3 | 50,4 | 110,6 | 119,3 |
Net profit (loss) | 19,4 | 3,6 | 2,7 | -23,5 |
Cash | 4,3 | 11,7 | 14,4 | 23,1 |
Net income from sale | 20 | 6 | 14,1 | 135 |
Liabilities and provisions for liabilities | 10,7 | 15,2 | 72,6 | 377,8 |
Working assets | 42,3 | 50,4 | 110,6 | 119,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 61,2 | 10,2 | 7,2 | -3 |
Equity capital to total assets | 74,7 | 69,9 | 34,3 | -35,6 |
Gross profit margin | 106,4 | 65,7 | 21,4 | -44,3 |
EBITDA Margin | 106,4 | 68,1 | 21,4 | -46,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 195 | 924 | 844 | -80 |
Current financial liquidity indicator | 3.958008289337158 | 3.3189759254455566 | 1.523108720779419 | -1,8 |
Net dept to EBITDA | 0.11903613805770874 | -0.8208578824996948 | -0.3548174202442169 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane